Research ArticleAccepted Article
Novel Biomarker of Collagen Degradation can Identify Patients Affected with both Axial Spondyloarthritis and Crohn's Disease
Signe Holm Nielsen, Andrew Stahly, Emilie H. Regner, Anne-Christine Bay-Jensen, Morten Karsdal and Kristine A. Kuhn
The Journal of Rheumatology June 2022, jrheum.220142; DOI: https://doi.org/10.3899/jrheum.220142
Signe Holm Nielsen
Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com
Andrew Stahly
Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com
Emilie H. Regner
Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com
Anne-Christine Bay-Jensen
Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com
Morten Karsdal
Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com
Kristine A. Kuhn
Sources of Funding: This work was supported by the Danish Research Foundation "Den Danske Forskningsfond" and the Danish Innovation Foundation (Innovationsfonden). Biomedicine and Biotechnology, Technical University of Denmark, Lyngby, Denmark; Department of Medicine, Division of Rheumatology, University of Colorado Anschutz Medical Campus, Aurora, CO. Conflict of interest: SHN, ACBJ and MAK are full-time employees at Nordic Bioscience A/S. Nordic Bioscience is a privately-owned, small–medium size enterprise (SME) partly focused on the development of biomarkers. None of the authors received fees, bonuses or other benefits for the work described in the manuscript. SHN, ACBJ and MK hold stocks in Nordic Bioscience A/S. Corresponding author: Signe Holm Nielsen, Herlev Hovedgade 207, DK-2730 Herlev, Denmark, E-mail: shn@nordicbio.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Novel Biomarker of Collagen Degradation can Identify Patients Affected with both Axial Spondyloarthritis and Crohn's Disease
Signe Holm Nielsen, Andrew Stahly, Emilie H. Regner, Anne-Christine Bay-Jensen, Morten Karsdal, Kristine A. Kuhn
The Journal of Rheumatology Jun 2022, jrheum.220142; DOI: 10.3899/jrheum.220142
Accepted manuscript
Novel Biomarker of Collagen Degradation can Identify Patients Affected with both Axial Spondyloarthritis and Crohn's Disease
Signe Holm Nielsen, Andrew Stahly, Emilie H. Regner, Anne-Christine Bay-Jensen, Morten Karsdal, Kristine A. Kuhn
The Journal of Rheumatology Jun 2022, jrheum.220142; DOI: 10.3899/jrheum.220142